Fluoxetine treatment of dysthymia in the elderly

Journal of Clinical Psychiatry

Volumn 57, Issue 6, 1996, Pages 254-256

  Nobler, Mitchell S ^a   Devanand, D P ^b   Kim, Min Kyung ^b   Fitzsimons, Linda M ^b   Singer, Tara M ^b   Turret, Nancy ^b   Sackeim, Harold A ^b   Roose, Steven P ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DYSTHYMIA; FEMALE; HUMAN; INSOMNIA; MALE; PRIORITY JOURNAL; RATING SCALE; RESTLESSNESS; SOMNOLENCE; VISUAL IMPAIRMENT;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; HUMANS; MALE; PILOT PROJECTS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0029948373     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Blazer D, Hughes DC, George LK. The epidemiology of depression in an elderly community population. Gerontologist 1987;27:281-287
2. Schneider LS, Reynolds CF, Lebowitz BD, et al, eds. Diagnosis and Treatment of Depression in Late Life. Washington, DC: American Psychiatric Press; 1994
3. Murphy E. The prognosis of depression in old age. Br J Psychiatry 1983; 142:111-119
4. Lee AS, Murray RM. The long-term outcome of Maudsley depressives. Br J Psychiatry 1988;153:741-751
5. Devanand DP, Nobler MS, Singer TM, et al. Is dysthymia a different disorder in the elderly? Am J Psychiatry 1994;151:1592-1599
6. Kocsis JH, Frances AJ, Voss C, et al. Imipramine treatment for chronic depression. Arch Gen Psychiatry 1988;45:253-257
7. Bakish D, Ravindran A, Hooper C, et al. Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder. Psychopharmacol Bull 1994;30:53-59
8. Stewart JW, McGrath PJ, Quitkin FM. Relevance of DSM-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Arch Gen Psychiatry 1989;46:1080-1087
9. Hellerstein DJ, Yanowitch P, Rosenthal J, et al. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 1993;150:1169-1175
10. Ravindran AV, Bialik RJ, Lapierre YD. Therapeutic efficacy of specific serotonin reuptake inhibitors (SSRIs) in dysthymia. Can J Psychiatry 1994;39: 21-26
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
12. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
13. Mason BJ, Kocsis JH, Leon AC, et al. Measurement of severity and treatment response in dysthymia. Psychiatric Annals 1993;23:625-631
14. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
15. Guy W, Petrie W, Cleary P. The incidence of treatment emergent symptoms under chlorpromazine and placebo conditions. Psychopharmacol Bull 1978;14:22-24
16. Tollefson GD, Holman SL. Analysis of the Hamilton depression rating scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression. Int Clin Psychopharmacol 1993;8: 253-259
17. Marin DB, Kocsis JH, Frances AJ, et al. Desipramine for the treatment of "pure" dysthymia versus "double" depression. Am J Psychiatry 1994;151: 1079-1080